Richard L. Wasserman
Expertise in
7
conditions

Dr. Richard L. Wasserman

Allergy and Immunology | Pediatrics
7777 Forest Lane, 
Dallas, TX 
Accepting New Patients
Expertise in
7
conditions
7777 Forest Lane, 
Dallas, TX 

Overview

Richard Wasserman is an Allergy and Immunologist and a Pediatrics provider practicing medicine in Dallas, Texas.

Dr. Wasserman is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Primary Immunodeficiency (PID), X-Linked Agammaglobulinemia, Common Variable Immune Deficiency, and Food Allergy.

Dr. Wasserman is board certified in American Board Of Pediatrics and American Board Of Allergy And Immunology . He is actively involved in clinical research, co-authoring 109 peer reviewed articles and participating in 8 clinical trials. Dr. Wasserman is currently accepting new patients.

Specialties

Allergy and Immunology
Pediatrics

Licenses

Allergy & Immunology in TX

Board Certifications

American Board Of Pediatrics
American Board Of Allergy And Immunology

Languages Spoken

English
Spanish

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Freedom Life
  • INSURANCE PLAN
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Allergy Partners of North Texas - Dallas
7777 Forest Lane, Dallas, TX 75230

Additional Areas of Focus

Dr. Wasserman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Asthma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Active_not_recruiting
Publish Date: July 25, 2025
Intervention Type: Biological
Study Phase: Phase 3
A Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
A Phase 1b/2a Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of CNP-201 in Subjects Ages 16-55 With Peanut Allergy
Enrollment Status: Terminated
Publish Date: December 20, 2023
Intervention Type: Drug
Study Drug: CNP-201
Study Phase: Phase 1
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects With Primary Immunodeficiency Diseases
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric Subjects With Primary Immunodeficiency Diseases
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Biological
Study Phase: Phase 3
A Phase 3, Multicenter, Open-label, Single-sequence, Cross-over, Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of IVIG-PEG Compared to Gamunex-C in Subjects With Primary Humoral Immunodeficiency
A Phase 3, Multicenter, Open-label, Single-sequence, Cross-over, Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of IVIG-PEG Compared to Gamunex-C in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: June 05, 2023
Intervention Type: Biological
Study Phase: Phase 3
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
An Open-Label, Single-Arm, Historically Controlled, Prospective, Multicenter Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Immune Globulin Intravenous (Human) GC5107 in Subjects With Primary Humoral Immunodeficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Biological
Study Phase: Phase 3
A Phase 3, Multicenter, Open-Label Study of the Safety, Tolerability, Efficacy, and PK of ProMetic BioTherapeutics IGIV (Human) 10% in Adults and Children With Primary Immunodeficiency Diseases
A Phase 3, Multicenter, Open-Label Study of the Safety, Tolerability, Efficacy, and PK of ProMetic BioTherapeutics IGIV (Human) 10% in Adults and Children With Primary Immunodeficiency Diseases
Enrollment Status: Completed
Publish Date: November 05, 2021
Intervention Type: Biological
Study Phase: Phase 3
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
A Clinical Investigation to Assess the Safety and Efficacy of Immune Globulin Intravenous (Human), 10% in Subjects With Primary Immunodeficiency Disorders
Enrollment Status: Completed
Publish Date: August 24, 2021
Intervention Type: Biological
Study Phase: Phase 3
View 6 Less Clinical Trials

109 Total Publications

Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).
Clinical Evaluation of Pharmacokinetics, Efficacy, and Safety of a 10% Immunoglobulin in Primary Immunodeficiency Disease (CARES10 Study).
Journal: Advances in therapy
Published: November 30, 2025
Similar Doctors
Expertise in
7
conditions
Dr. Sandeep K. Gupta
Allergy and Immunology
Expertise in
7
conditions
Dr. Sandeep K. Gupta
Allergy and Immunology
Referral may be required
Before you request

North Texas Allergy And Asthma Associates

3417 Gaston Ave, Suite 760, 
Dallas, TX 
 (8.4 miles away)
214-369-1907
Languages Spoken:
English, Hindi, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Sandeep Gupta is an Allergy and Immunologist practicing medicine in Dallas, Texas. Dr. Gupta is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Eosinophilic Esophagitis, Eosinophilic Enteropathy, Eosinophilic Colitis, Endoscopy, and Coronary Artery Bypass Graft (CABG). Dr. Gupta is board certified in Allergy And Immunology- American Board Of Allergy And Immunology and Allergy & Immunology- American Board Of Allergy And Immunology. Dr. Gupta is currently accepting new patients.

Expertise in
13
conditions
Dr. Robert W. Sugerman
Allergy and Immunology | Pediatrics
Expertise in
13
conditions
Dr. Robert W. Sugerman
Allergy and Immunology | Pediatrics
Referral may be required

Allergy Partners Of North Texas - Dallas

7777 Forest Lane, 
Dallas, TX 
 (0.1 miles away)
972-566-7788
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Robert Sugerman is an Allergy and Immunologist and a Pediatrics provider practicing medicine in Dallas, Texas. Dr. Sugerman is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Primary Immunodeficiency (PID), Common Variable Immune Deficiency, Sinusitis, and Allergic Rhinitis. Dr. Sugerman is board certified in American Board Of Pediatrics and American Board Of Allergy And Immunology. Dr. Sugerman is currently accepting new patients.

Expertise in
14
conditions
Dr. Richard F. Herrscher
Allergy and Immunology
Expertise in
14
conditions
Dr. Richard F. Herrscher
Allergy and Immunology
Referral may be required
Before you request

AIR Care - Plano

3600 Communications Pkwy, Ste 675, 
Plano, TX 
 (10.0 miles away)
972-473-7544
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Richard Herrscher is an Allergy and Immunologist practicing medicine in Plano, Texas. Dr. Herrscher is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Mast Cell Activation Syndrome (MCAS), Primary Immunodeficiency (PID), Sinusitis, and Allergic Rhinitis. Dr. Herrscher is currently accepting new patients.

Frequently Asked Questions about Dr. Richard L. Wasserman

How do I make an appointment with Dr. Richard L. Wasserman?

You can book an appointment with Dr. Richard L. Wasserman by calling their office at 972-566-7788. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Richard L. Wasserman a top-rated expert for Primary Immunodeficiency (PID)?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Richard L. Wasserman is classified as an Elite expert for Primary Immunodeficiency (PID), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Richard L. Wasserman specialize in?

While Dr. Richard L. Wasserman is a Allergy and Immunology, they have specific expertise in Primary Immunodeficiency (PID), X-Linked Agammaglobulinemia, and Common Variable Immune Deficiency. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Allergy and Immunology.

Does Dr. Richard L. Wasserman participate in research or clinical trials?

Yes. Dr. Richard L. Wasserman has published 109 articles and abstracts on conditions like Primary Immunodeficiency (PID). You can view a list of Dr. Richard L. Wasserman's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Richard L. Wasserman accept my insurance?

Dr. Richard L. Wasserman accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 972-566-7788 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wasserman's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile